Invesaro

Stocks Consumer staples XAGE

OTC · Consumer staples

Longevity Health Holdings, Inc. (XAGE)

Longevity Health Holdings, Inc. brought in $1.7M of revenue over the twelve months to June 30, 2026, up 60.3% from a year earlier. It posted a net loss of $6.8M. In fiscal 2025 capital spending exceeded operating cash flow by $3.3M. At June 30, 2026 it held $35.5K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch XAGE in 60 seconds
Price
$0.16
+0.06% on the day · September 25, 2026
52-week range $0.16 to $0.84
Market cap
$386.2K
Revenue (last 12 months)
$1.7M
+60.3% year on year
Net margin
-404.8%

What Longevity Health Holdings, Inc. does

Longevity Health Holdings, Inc. is registered with the SEC under industry code SIC 2840 (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics). Its shares trade on OTC under the ticker XAGE.

Revenue and profit by year

Revenue
FY23: $0 $0 FY23FY24: $50.3K $50.3K FY24FY25: $1.9M $1.9M FY25
Net income
FY21: -$329.4K -$329.4K FY21FY22: -$9.1M -$9.1M FY22FY23: -$15.4M -$15.4M FY23FY24: -$10.4M -$10.4M FY24FY25: -$6.9M -$6.9M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$1.9M-$7.1M-$6.9M-$4.83-$3.3M
2024$50.3K-$5M-$10.4M-$14.56n/a
2023$0-$5.9M-$15.4M-$43.38-$8.4M
2022n/a-$5.5M-$9.1M-$162.54-$3.4M
2021n/a-$467.4K-$329.4Kn/an/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 14, 2025. Not a date the company has announced. See the report calendar

Where XAGE ranks in Consumer staples

Revenue$1.9M
#145 of 154 in Consumer staples · Bottom 6%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer staples

Latest SEC filings

What Longevity Health Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 8, 2026
  2. September 8, 2026
  3. September 8, 2026
  4. September 4, 2026
  5. August 17, 2026
  6. August 17, 2026
  7. August 14, 2026
  8. August 14, 2026
  9. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 21% to $396K versus the same quarter last year; diluted EPS -$0.76 versus -$1.56.
  10. August 14, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on April 8, 2026. Insider transactions on SEC

Insider trades

What the people running Longevity Health Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
March 16, 2026 Ajjarapu J. RamChief Executive Officer, Director, 10% owner Boughtindirect 689,656 $0.29 $200K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns XAGE

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Ajjarapu J. Ram13D, may seek influence with 1 related filers 27.9% 689,656 April 8, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 689,656 shares in total, about $107.6K at the last price.

HolderSharesAs of
Ajjarapu J. RamChief Executive Officer, Director, 10% owner 689,656689,656 held indirectly March 16, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about XAGE

What does Longevity Health Holdings, Inc. do?

Longevity Health Holdings, Inc. is registered with the SEC under industry code SIC 2840 (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics). Its shares trade on OTC under the ticker XAGE.

Is Longevity Health Holdings, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $6.8M on revenue of $1.7M.

How much revenue does Longevity Health Holdings, Inc. make?

Over the twelve months to June 30, 2026 Longevity Health Holdings, Inc. reported revenue of $1.7M. That is 60.3% more than a year earlier.

When did Longevity Health Holdings, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the securities offering prospectus from September 8, 2026.

Similar companies

Compare XAGE with

Compare XAGE with any company

Follow XAGE

Get an email when Longevity Health Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow XAGE: get an email when it files

Where the numbers come from

Financial figures are the values Longevity Health Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.